Premium
Modified conservative management of mandibular ameloblastoma: a 13‐year experience in a Malaysian tertiary care centre
Author(s) -
Yew C. C.,
Ismail R. B.,
Md Zin M. N. B.,
Yap H. F.,
Chan H. K.
Publication year - 2020
Publication title -
oral surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.156
H-Index - 11
eISSN - 1752-248X
pISSN - 1752-2471
DOI - 10.1111/ors.12486
Subject(s) - ameloblastoma , medicine , enucleation , ostectomy , dentistry , oral and maxillofacial surgery , tertiary care , surgery , maxilla
Purpose Although surgical resection is routinely used to treat mandibular ameloblastoma, it associates with aesthetic and functional complications, hence a modified conservative management (MCM) comprising surgical enucleation, peripheral ostectomy and chemical cauterisation was practiced in a tertiary care centre in northern Malaysia. This study aims to access the treatment outcome and potential use of MCM. Methods This cross‐sectional study assessed the demographic and clinical profiles of mandibular ameloblastomas managed with MCM and their outcomes from year 2006 to 2019. Results A total of 13 cases of mandibular ameloblastoma were identified between 2006 and 2019 with MCM, which consisted of nine cases of solid/ multicystic ameloblastoma (SMA) (84.6%), and two cases of unicystic ameloblastoma (UA). Over mean review duration of 57 month, three recurrences (23.2%) were reported for SMA group and no recurrence was found for UA cases. Conclusions The relatively low recurrence rates suggest that MCM has potential to be used as an alternative treatment for mandibular ameloblastoma. Further well‐designed prospective study is recommended to understand the effectiveness of MCM, which hopefully can evolve towards a minimally invasive surgical approach in treating mandibular ameloblastoma.